LENTINEXT

Gene transfer agent for preventing or treating human diseases (vector); biological vector for medical, medicinal or veterinary purposes; biological recombinant vector for medical, medicinal or veterinary purposes; preparations for gene recombination for medical, medicinal or veterinary purposes; nucleic acid for medical, medicinal or veterinary purposes; biopharmaceuticals for the treatment of auto-immune diseases; biopharmaceuticals for the treatment of cancer; diagnostic biomarker reagents for medical purposes; reagents for use in medical genetic testing; pharmaceutical preparations for gene therapy and diagnosis; pharmaceutical preparations for the diagnosis and the treatment of diseases; anti-cancer preparations; antibiotics; anti-viral agents; anti-infectives; pharmaceutical products for the treatment of viral diseases; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for the treatment of cells; cells for medical purposes